Enzyme Acquires Myso Finance and Expands to Solana in Major 2024 Growth
Enzyme Protocol marked significant expansion in 2024 with key developments:
- Acquired Myso Finance, the leading on-chain covered calls protocol
- Invested in Trade Neutral to expand services to Solana ecosystem
- Extended protocol to Arbitrum and integrated GMX
- Launched first Advanced Automated Loops with Stader Labs
- Reached $220M in Assets Under Technology with 1,400+ creations
2025 roadmap focuses on:
- Completing Solana integration
- Expanding to additional networks
- Launching V5 protocol update
- Strengthening global infrastructure position
The protocol has maintained steady growth since its 2017 launch as Melon Protocol, navigating market cycles while expanding capabilities.